Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy
Yang Li, Yun Liu, Dan Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12069-12100
Closed Access | Times Cited: 9

Showing 9 citing articles:

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4916-4935
Closed Access | Times Cited: 7
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 6
Recent Progress in Poly(ADP–Ribose) Polymerase‐1 Inhibitors for Application in Cancer
Anuradha Mehra, Sayemul Islam, Rekha Sangwan
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 3
Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging
Chunfeng He, Hui Shi, Boyu Tan, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3840-3853
Closed Access | Times Cited: 3
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Yijun Xie, Di Xiao, Duo Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer
Yi‐Ru Bai, Weiguang Yang, Rui Jia, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 214-273
Closed Access
Receptor tyrosine kinases in breast cancer treatment: unraveling the potential
Qi Yu, Shumin Deng, Kuan-Song Wang
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4172-4196
Closed Access
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Page 1

Scroll to top